When was BrightGene founded?

BrightGene was founded in 2001 and raised its 1st funding round 18 years after it was founded.

Where is BrightGene located?

BrightGene is headquartered in Suzhou, China.

How many employees does BrightGene have?

As of Sep 30, 2026, the latest employee count at BrightGene is 22.

Is BrightGene a funded company?

BrightGene is a funded company, having raised a total of $80M across 2 funding rounds to date. The company's 1st funding round was a $***** Series C round, raised on Jan 07, 2019.

When was the latest funding round of BrightGene?

BrightGene's latest funding was a $***** Series C round on Mar 12, 2026, with participation from 0 investor.

Where does BrightGene rank among its competitors?

BrightGene ranks 15th amongst 198 active competitors, of which 13 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was BrightGene, which secured an undisclosed amount in Mar, 2026.

Who are the top competitors of BrightGene?

BrightGene's top competitors include Bayer, Wockhardt and Biological E. Among them, BrightGene secured the most recent funding round in March, 2026.

BrightGene - 2026 Company Profile, Team, Funding & Competitors

BrightGene is a series C company based in Suzhou (China), founded in 2001 by Jiandong Yuan. It operates as a Manufacturer of pharmaceutical formulations, active pharmaceutical ingredients, and veterinary drugs. BrightGene has raised $80M in funding from Sequoia Capital China and Highlight Capital Partners. The company has 198 active competitors, including 13 funded and 53 that have exited. Its top competitors include companies like Bayer, Wockhardt and Biological E.

Company Details

Manufacturer of pharmaceutical formulations, active pharmaceutical ingredients, and veterinary drugs. The company develops and produces a range of pharmaceutical products, including formulations for human use and active pharmaceutical ingredients. It also offers products related to veterinary medicine. A robust research and development system supports innovation and quality control throughout the production process. The company maintains comprehensive production and quality systems.

Website: www.bright-gene.com
Email ID: *****@bright-gene.com
Phone Number: +0512 **********

Key Metrics

Founded Year

2001

Location

Suzhou, China

Stage

Series C

Total Funding

$80M in 2 rounds

Latest Funding Round

Series C, Mar 12, 2026, $*****

Investors

Sequoia Capital China & 10 more

Ranked

15^th among 198 active competitors

Employee Count

22 as on Sep 30, 2026

Investment & Acquisitions

Aoli Biotechnology & 2 more

Similar Companies

Bayer & 211 more

View BrightGene's full profile

BrightGene has raised a total funding of $80M over 2 rounds. Its first funding round was on Jan 07, 2019. BrightGene has 11 institutional investors.

Here is the list of recent funding rounds of BrightGene:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 12, 2026	4458510	Series C	8752427	2674913	1017706	2105119
Jan 07, 2019	9679817	Series C	3361311	9548359	Highlight Capital Partners & 1 more	GF Securities

Access funding benchmarks and valuations. Sign up today!

View details of BrightGene's funding rounds and investors

The founders of BrightGene is Jiandong Yuan.

Here are the details of BrightGene's key team members:

Jiandong Yuan: Founder & President of BrightGene.

View details of BrightGene's Founder profiles and Board Members

BrightGene's employee count trend

BrightGene has 22 employees as of Sep 26. Here is BrightGene's employee count trend over the years:

Uncover BrightGene's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BrightGene include Bayer, Wockhardt and Biological E. Here is the list of Top 10 competitors of BrightGene, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bayer 1863, Leverkusen (Germany), Public	Manufacturer of drugs	-	Digital Pharma Lab, B Capital Fund & 9 others	76/100
2nd	Wockhardt 1967, Mumbai (India), Public	Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients	-	HDFC Mutual Fund, Tata Mutual Fund & 12 others	71/100
3rd	Biological E 1953, Hyderabad (India), Funding Raised	Developer of vaccines for treating multiple diseases	-	Gates, IFC & 3 others	69/100
4th	Cipla 1935, Mumbai (India), Public	Manufacturer of APIs, generic drugs, and formulation development services	-	MUFG, Eight Roads Ventures & 3 others	69/100
5th	Emcure 1981, Pune (India), Public	Developer, manufacturer, and markets a broad range of pharmaceutical products	$50M	Blackstone, Bain Capital	68/100
6th	Amneal 2002, Bridgewater (United States), Public	Manufacturer of generics formulations	-	Tarsadia, GE Capital & 2 others	68/100
7th	Strides Pharma Science 1990, Bengaluru (India), Public	Manufacturer of generic pharmaceutical products and various specialty medical formulations	-	InvAscent, Oman India Joint Investment Fund ... & 2 others	68/100
8th	Lupin 1968, Mumbai (India), Public	Manufacturer of pharmaceutical products, including generics, biosimilars, and active pharmaceutical ingredients	-	Cipher International, AbbVie & 5 others	67/100
9th	Aurobindo Pharma 1986, Hyderabad (India), Public	Provider of generic biocatalytic products	-	Affirma Capital, India Capital Growth & 4 others	66/100
10th	Dr. Reddy's Laboratories 1984, Hyderabad (India), Public	Multinational pharmaceutical company that develops and manufactures innovative and medicines to improve patient health	-	Life Insurance Corporation of India, Gates ... & 4 others	65/100
15th	BrightGene 2001, Suzhou (China), Series C	Manufacturer of pharmaceutical formulations, active pharmaceutical ingredients, and veterinary drugs	$80M	GF Securities, Overture Wealth & 9 others	64/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on BrightGene's competitors? Click here to see the top ones

BrightGene has made 3 investments including Aoli Biotechnology, Citryll and Particella. BrightGene has not made any acquisitions as of now.

Here is the list of its investments:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jan 29, 2024	Investments	Aoli Biotechnology	2022	-
Jul 03, 2019	Investments	Citryll	2015	Amsterdam (Netherlands)
Aug 08, 2018	Investments	Particella	2016	San Francisco (United States)